Dr. Nagarajan was from and Drs. Kenney and Galan are from the Department of Pathology, Yale School of Medicine, New Haven, Connecticut. Dr. Nagarajan currently is from the Department of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston. Dr. Kenney also is from the Veterans Administration Hospital, West Haven, Connecticut. Dr. Galan also is from the Department of Dermatology, Yale School of Medicine. Dr. Drost is from the Department of Dermatology, Danbury Veterans Administration Primary Care Center, Connecticut.
The authors report no conflict of interest.
Correspondence: Anjela Galan, MD, 15 York St, LMP 5031, New Haven, CT 06520-8059 (anjela.galen@yale.edu).
Figure 3. Proposed mechanism of tumorigenesis in hereditary leiomyomatosis and renal cell carcinoma syndrome. In the presence of functional fumarate hydratase (FH), hypoxia-inducible factor (HIF) is degraded, resulting in normoxia (top panel). In the absence of functional FH, there is accumulation of fumarate, while malate levels decrease, and the glucose metabolism through Krebs cycle shifts toward anaerobic glycolysis, even when sufficient oxygen is present to support respiration (bottom panel). Increased fumarate inhibits HIF prolyl hydroxylase (HPH), which leads to stabilization of HIF, a transcription factor, that enhances anaerobic glycolysis, cellular proliferation, and angiogenesis, leading to tumor growth.
Patients with renal tumor–associated hereditary syndromes may present initially to dermatologists; therefore, it is important to recognize the cutaneous manifestations of these conditions because early diagnosis of renal cancer may prove to be lifesaving.